Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.167x

Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has a cash flow conversion efficiency ratio of -0.167x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-35.65 Million ≈ $-385.57K USD) by net assets (Rs213.04 Million ≈ $2.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biofil Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Biofil Chemicals & Pharmaceuticals Limit for a breakdown of total debt and financial obligations.

Biofil Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Carlin Gold Corporation V:CGD	-0.003x
Signature Resources Ltd V:SGU	0.709x
Deveron UAS Corp V:FARM	0.031x
ScandiDos AB ST:SDOS	0.015x
ChargePanel AB ST:CHARGE	-0.513x
Ao World LSE:AO	0.452x
Canterbury Resources Ltd AU:CBY	-0.060x
DONTNOD Entertainment SA PA:ALDNE	-0.071x

Annual Cash Flow Conversion Efficiency for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Biofil Chemicals & Pharmaceuticals Limit (BIOFILCHEM) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs187.82 Million ≈ $2.03 Million	Rs-19.24 Million ≈ $-208.03K	-0.102x	-177.88%
2024-03-31	Rs182.03 Million ≈ $1.97 Million	Rs23.94 Million ≈ $258.87K	0.132x	+2135.04%
2023-03-31	Rs173.01 Million ≈ $1.87 Million	Rs-1.12 Million ≈ $-12.09K	-0.006x	+50.52%
2022-03-31	Rs168.38 Million ≈ $1.82 Million	Rs-2.20 Million ≈ $-23.78K	-0.013x	-118.96%
2021-03-31	Rs161.29 Million ≈ $1.74 Million	Rs11.11 Million ≈ $120.14K	0.069x	+14.64%
2020-03-31	Rs148.83 Million ≈ $1.61 Million	Rs8.94 Million ≈ $96.70K	0.060x	-34.69%
2019-03-31	Rs136.50 Million ≈ $1.48 Million	Rs12.56 Million ≈ $135.80K	0.092x	+161.29%
2018-03-31	Rs131.67 Million ≈ $1.42 Million	Rs4.64 Million ≈ $50.14K	0.035x	-37.16%
2017-03-31	Rs126.96 Million ≈ $1.37 Million	Rs7.11 Million ≈ $76.94K	0.056x	+347.18%
2016-03-31	Rs109.07 Million ≈ $1.18 Million	Rs1.37 Million ≈ $14.78K	0.013x	+1051.90%
2015-03-31	Rs84.15 Million ≈ $910.03K	Rs91.53K ≈ $989.89	0.001x	-95.95%
2014-03-31	Rs78.63 Million ≈ $850.35K	Rs2.11 Million ≈ $22.84K	0.027x	+253.87%
2013-03-31	Rs73.62 Million ≈ $796.22K	Rs-1.29 Million ≈ $-13.90K	-0.017x	+37.76%
2012-03-31	Rs68.36 Million ≈ $739.31K	Rs-1.92 Million ≈ $-20.73K	-0.028x	+84.95%
2011-03-31	Rs67.02 Million ≈ $724.79K	Rs-12.49 Million ≈ $-135.03K	-0.186x	-111.61%
2010-03-31	Rs17.27 Million ≈ $186.81K	Rs27.73 Million ≈ $299.89K	1.605x	+993.82%
2009-03-31	Rs11.99 Million ≈ $129.64K	Rs-2.15 Million ≈ $-23.28K	-0.180x	-173.13%
2008-03-31	Rs14.78 Million ≈ $159.86K	Rs3.63 Million ≈ $39.26K	0.246x	--

About Biofil Chemicals & Pharmaceuticals Limited

NSE:BIOFILCHEM India Drug Manufacturers - Specialty & Generic

Market Cap

$5.99 Million

Rs554.12 Million INR

Market Cap Rank

#28000 Global

#1579 in India

Share Price

Rs34.05

Change (1 day)

+1.16%

52-Week Range

Rs25.79 - Rs54.44

All Time High

Rs339.15